Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
作者信息
Cheah Chan Y, Seymour John F
机构信息
Department of Haematology, Peter MacCallum Cancer Centre , East Melbourne, Victoria , Australia and University of Melbourne , Parkville, Victoria , Australia.
出版信息
Leuk Lymphoma. 2014 Mar;55(3):471-3. doi: 10.3109/10428194.2013.830306. Epub 2013 Nov 14.
PMID:23906017
Abstract
摘要
相似文献
1
Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?在利妥昔单抗时代，弥漫性大B细胞淋巴瘤是否仍需要针对中枢神经系统的特异性预防措施？
Leuk Lymphoma. 2014 Mar;55(3):471-3. doi: 10.3109/10428194.2013.830306. Epub 2013 Nov 14.
2
Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.利妥昔单抗对弥漫性大 B 细胞淋巴瘤患者中枢神经系统复发的影响：系统评价和荟萃分析。
Leuk Lymphoma. 2014 Mar;55(3):509-14. doi: 10.3109/10428194.2013.811239. Epub 2013 Jul 29.
3
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.利妥昔单抗时代弥漫大 B 细胞淋巴瘤患者中枢神经系统（CNS）预防对 CNS 复发的发生率和危险因素的影响：单中心经验和文献复习。
Br J Haematol. 2012 Oct;159(1):39-49. doi: 10.1111/j.1365-2141.2012.09247.x. Epub 2012 Jul 31.
4
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.中枢神经系统（CNS）复发弥漫性大 B 细胞淋巴瘤（DLBCL）：利妥昔单抗治疗前后。
Ann Hematol. 2011 Jul;90(7):809-18. doi: 10.1007/s00277-010-1150-7. Epub 2011 Jan 13.
5
Rituximab maintenance therapy in central nervous system lymphoma?利妥昔单抗在中枢神经系统淋巴瘤中的维持治疗？
Leuk Lymphoma. 2009 Oct;50(10):1555-6. doi: 10.1080/10428190903254409.
6
Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.弥漫性大 B 细胞淋巴瘤累及肾脏：结局和中枢神经系统复发风险。
Haematologica. 2011 Jul;96(7):1002-7. doi: 10.3324/haematol.2011.041277. Epub 2011 Apr 12.
7
Isolated central nervous system relapse in a patient with diffuse large B cell lymphoma.弥漫性大B细胞淋巴瘤患者发生孤立性中枢神经系统复发。
BMJ Case Rep. 2012 Jan 23;2012:bcr1220115275. doi: 10.1136/bcr.12.2011.5275.
8
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.利妥昔单抗时代弥漫性大 B 细胞淋巴瘤患者的中枢神经系统事件。
Cancer Sci. 2012 Feb;103(2):245-51. doi: 10.1111/j.1349-7006.2011.02139.x. Epub 2011 Nov 29.
9
Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab.侵袭性B细胞淋巴瘤继发中枢神经系统受累经全身大剂量化疗联合鞘内注射利妥昔单抗治疗后的持续缓解及长期生存
Leuk Lymphoma. 2008 Oct;49(10):2018-21. doi: 10.1080/10428190802311375.
10
Primary renal diffuse large B-cell lymphoma with central nervous system involvement: a rare case report and literature review.原发性肾弥漫性大B细胞淋巴瘤伴中枢神经系统受累：1例罕见病例报告及文献复习
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7045-9. eCollection 2015.
Zotero 插件